August 7, 2019 by Chain Drug Review
Aetna, CVS Health, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I.— CVS Health stock rose nearly 6% in pre-market trading on Wednesday after the company reported strong second quarter operating results for the three months ending June 30, 2019. Second quarter earnings beat Wall Street’s expectations and the company significantly raised its own projection for full-year earnings. “We posted strong second quarter results, with
July 29, 2019 by Chain Drug Review
Aetna, CVS Health, Dr. Alan Lotvin, HealthHUB, Karen Lynch, Path to Better Health Study by CVS Health
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — Millennials may be the first digital natives, but that love of technology could also be harming their health, according to the Path to Better Health Study by CVS Health. The study, now in its second year, explores consumer health goals and asks providers what they need to help patients reach those goals.
May 14, 2019 by Chain Drug Review
Aetna, Aurora Health Care, Aurora Pharmacy
Leading Headlines, Pharmacy, Retail News, Uncategorized
MILWAUKEE – Aurora Health Care, part of Advocate Aurora Health, and Aetna, a CVS Health business, Monday announced that Aurora Pharmacy has joined Aetna’s Medicare network of preferred pharmacies. Effective immediately, Aetna Medicare members with drug coverage can fill their prescriptions for preferred pharmacy copays at any Aurora Pharmacy in Wisconsin. “Becoming an Aetna Preferred Pharmacy is one more way
March 1, 2019 by Chain Drug Review
Aetna, CVS Health, Jonathan Roberts, Roshan Navagamuwa
Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — According to published reports in the Wall Street Journal, CVS Health has named a new chief information officer tasked with integrating its information technology and data with IT systems used by Aetna, which the drugstore chain acquired last year in a $70 billion deal. Roshan Navagamuwa, who over the past year served
February 26, 2019 by Chain Drug Review
Aetna, CVS
Featured Articles, Leading Headlines, Retail News
WASHINGTON — A federal judge has been formally asked by the Justice Department to approve CVS Health’s acquisition of Aetna Inc. District Court Judge Richard Leon had rebuked the government and the companies late last year for closing the $69 billion dollar deal prior to approval of a consent order. In response, CVS offered to
February 13, 2019 by Chain Drug Review
Aetna, CVS Health, HealthHUBs, Kevin Hourican, New concept stores
Featured Articles, Leading Headlines, Pharmacy, Retail News
HOUSTON — CVS Health has unveiled a new health-focused store concept here that’s designed to help the pharmacy chain become more of a health-care provider. The three HealthHUB pilot stores that opened in the Houston area in December are part of the company’s vision for its $70 billion acquisition of health insurer Aetna. In addition
February 12, 2019 by Chain Drug Review
Aetna, Aetna Foundation, National Health Challenge
Leading Headlines, Supplier News
HARTFORD, Conn. — As part of an ongoing commitment to supporting community health and wellness, the Aetna Foundation today announced the two grand prize winners of the Healthiest Cities & Counties Challenge (the Challenge). The Mecklenburg County, N.C., Village HeartBEAT program won the $500,000 grand prize from the mid-sized city or county category (population 250,001
January 29, 2019 by Chain Drug Review
Aetna, Alan Lotvin, Apple Watch, Attain, CVS Health, Jeff Williams
Featured Articles, Leading Headlines, Technology
BOSTON — Aetna, a CVS Health business, has launched Attain, a unique health experience designed by Aetna in collaboration with Apple. Through the use of an Apple Watch, the Attain app will provide Aetna members personalized goals, track their daily activity levels, recommend healthy actions, and ultimately reward them for taking these actions to improve their
January 24, 2019 by Chain Drug Review
Aetna, Eva Boratto, Vitality Re X Limited
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — CVS Health announced that Aetna, a CVS Health business, has entered into a four-year reinsurance arrangement with Vitality Re X Limited as part of its long-term capital management strategy. The arrangement allows CVS Health to reduce its required capital and provides $200 million of collateralized excess of loss reinsurance coverage on a portion of Aetna’s
December 19, 2018 by Chain Drug Review
Aetna, CVS Health, CVS-Aetna deal, U.S. District Judge Richard Leon
Featured Articles, Leading Headlines
WASHINGTON—According to various published reports, a federal judge on Tuesday “softened” his previous suggestion that he would likely order CVS Health to halt its integration of Aetna. U.S. District Judge Richard Leon in recent weeks had voiced some concerns about the companies’ settlement with Justice Department antitrust enforcers that allowed the nearly $70 billion deal
December 10, 2018 by Jeffrey Woldt
Aetna, CVS, CVS Health, CVS-Aetna merger
Issue 12-10-2018, Opinion
U.S. district court judge Richard Leon put somewhat of a damper on CVS Health’s merger with Aetna earlier this month when he indicated that he might order a halt to the integration of the companies, which finalized their $78 billion tie-up in late November after winning approval from the Department of Justice and state regulators.
November 28, 2018 by Chain Drug Review
Aetna, CVS Health, CVS Pharmacy, CVS-Aetna deal, Larry Merlo
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. – CVS Health today announced that it has completed its acquisition of Aetna establishing CVS Health as the nation’s premier health innovation company. “Today marks the start of a new day in health care and a transformative moment for our company and our industry,” declared CVS Health president and chief executive officer Larry Merlo.
September 27, 2018 by Chain Drug Review
Aetna, CVS Health-Aetna, Inc. (WellCare), WellCare Health Plans
Business, Leading Headlines, Pharmacy, Retail News
OVERLAND PARK, Kan. — Ahead of its deal with CVS, Aetna announced an agreement to divest all of Aetna’s standalone Medicare Part D business to a subsidiary of WellCare Health Plans, Inc. (WellCare). The company said the divestiture is subject to the completion of CVS Health’s proposed acquisition of Aetna, regulatory approvals and other customary
June 6, 2018 by Chain Drug Review
Aetna, CVS Health, CVS Health-Aetna, David Denton, Dr. Alan M. Lotvin, Dr. Harold Paz, Dr. Troyen Brennan, Jon Roberts, Jr., Karen Lynch, Larry Merlo, Lisa Bisaccia, Mark Bertolini, Meg McCarthy, Richard di Benedetto, Rick Jelinek, Shawn Guertin, Steven Kelmar, Thomas Moriarty, Thomas Sabatino
Business, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has announced the management team that, following the close of the Aetna acquisition, will lead the combined company into the future. Aetna will operate as a stand-alone business unit within the CVS Health enterprise following the close and will be led by members of its current management team. In addition,